Brokerages expect Merit Medical Systems, Inc. (NASDAQ:MMSI) to announce $0.36 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Five analysts have provided estimates for Merit Medical Systems’ earnings. The lowest EPS estimate is $0.35 and the highest is $0.38. Merit Medical Systems reported earnings per share of $0.31 in the same quarter last year, which would suggest a positive year-over-year growth rate of 16.1%. The company is expected to issue its next earnings report after the market closes on Tuesday, April 23rd.
On average, analysts expect that Merit Medical Systems will report full-year earnings of $2.01 per share for the current year, with EPS estimates ranging from $1.99 to $2.04. For the next fiscal year, analysts anticipate that the business will report earnings of $2.33 per share, with EPS estimates ranging from $2.30 to $2.38. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side analysts that follow Merit Medical Systems.
Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings results on Tuesday, February 26th. The medical instruments supplier reported $0.48 EPS for the quarter, topping the consensus estimate of $0.45 by $0.03. Merit Medical Systems had a net margin of 4.76% and a return on equity of 11.26%. The business had revenue of $232.25 million for the quarter, compared to analysts’ expectations of $231.03 million. During the same quarter last year, the company posted $0.33 earnings per share. The company’s quarterly revenue was up 21.7% compared to the same quarter last year.
Shares of MMSI stock traded up $0.20 during trading hours on Monday, hitting $62.55. 258,200 shares of the company were exchanged, compared to its average volume of 347,796. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.32 and a current ratio of 2.45. Merit Medical Systems has a one year low of $44.05 and a one year high of $66.34. The stock has a market capitalization of $3.44 billion, a price-to-earnings ratio of 37.01, a PEG ratio of 2.68 and a beta of 1.11.
In other Merit Medical Systems news, CFO Raul Jr. Parra sold 5,000 shares of Merit Medical Systems stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $60.20, for a total transaction of $301,000.00. Following the transaction, the chief financial officer now directly owns 1,000 shares in the company, valued at approximately $60,200. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Michael E. Stillabower sold 10,000 shares of Merit Medical Systems stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $58.05, for a total transaction of $580,500.00. Following the transaction, the director now owns 63,618 shares in the company, valued at $3,693,024.90. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 41,216 shares of company stock worth $2,465,617. Corporate insiders own 5.16% of the company’s stock.
A number of hedge funds and other institutional investors have recently bought and sold shares of MMSI. FMR LLC grew its position in Merit Medical Systems by 175.4% during the 4th quarter. FMR LLC now owns 1,636,479 shares of the medical instruments supplier’s stock worth $91,332,000 after purchasing an additional 1,042,364 shares in the last quarter. Norges Bank acquired a new stake in shares of Merit Medical Systems during the 4th quarter valued at $34,188,000. Jennison Associates LLC acquired a new stake in shares of Merit Medical Systems during the 4th quarter valued at $33,885,000. Vanguard Group Inc boosted its stake in shares of Merit Medical Systems by 11.0% during the 3rd quarter. Vanguard Group Inc now owns 5,286,818 shares of the medical instruments supplier’s stock valued at $324,875,000 after buying an additional 522,994 shares during the period. Finally, Vanguard Group Inc. boosted its stake in shares of Merit Medical Systems by 11.0% during the 3rd quarter. Vanguard Group Inc. now owns 5,286,818 shares of the medical instruments supplier’s stock valued at $324,875,000 after buying an additional 522,994 shares during the period. Hedge funds and other institutional investors own 97.77% of the company’s stock.
About Merit Medical Systems
Merit Medical Systems, Inc manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions.
Further Reading: What is Call Option Volume?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.